Jumo Health, a Patient Experience Organization, announced a strategic partnership with Areti Health, an AI technology company, to advance the innovation and execution of PRISM™, Jumo Health's readiness-based clinical trial recruitment, enrollment, and retention system.

The partnership expands the delivery capabilities behind PRISM as sponsors and CROs look for more reliable ways to manage the gap between medical eligibility and durable participation. It brings Jumo Health's clinical, behavioral, health-literacy, and governance expertise together with Areti Health's conversational, generative, and agentic AI technology.

Jumo HealthPatient readiness, behavioral science, health literacy, and governed trial execution
Areti HealthConversational, generative, and agentic AI delivery capabilities
Shared focusMore prepared patients, stronger advancement decisions, and durable participation

Addressing the readiness gap.

Clinical research has become increasingly effective at identifying people who appear to meet protocol criteria. The industry can use claims, electronic health records, laboratory data, genetic information, provider networks, and sophisticated matching tools to locate potential participants with greater precision.

That progress has not eliminated screen failure after consent, early withdrawal, protocol deviations, site escalation, or rescue recruitment. These downstream outcomes often develop because patients enter study workflows before the cognitive, emotional, practical, and behavioral realities of participation have been fully understood or supported.

PRISM was created to treat readiness as a measurable and governed execution variable. It evaluates the conditions that influence whether a patient can advance, remain, and complete, then connects those insights to education, pre-screening, site handoff, ongoing monitoring, and intervention.

Advancing how readiness is operationalized.

Scaling readiness-based execution requires more than adding an automated conversation to an existing recruitment funnel. Patient interactions must operate within the realities of regulated clinical research. They must follow defined protocol logic, communicate within approved boundaries, preserve oversight, support escalation, and generate information that study teams can use responsibly.

Areti Health strengthens the delivery layer within PRISM. Its AI capabilities support adaptive patient interactions, intelligent workflow coordination, and continuity across channels while Jumo Health provides the readiness logic, behavioral framework, patient-experience design, clinical governance, and execution model.

Together, the companies are advancing capabilities that can:

  • Engage patients through adaptive, governed conversations.
  • Translate protocol requirements into patient-relevant understanding.
  • Identify confusion, hesitation, logistical strain, and other readiness friction earlier.
  • Support protocol-aligned pre-screening and feasibility validation.
  • Coordinate responsible advancement and site handoff.
  • Monitor readiness as participation conditions change.

Why the partnership matters.

Readiness-based execution demands a system that can interpret signals, guide decisions, and adapt support over time. Static education may improve awareness. Point automation may accelerate isolated tasks. Neither alone governs the complete transition from identification to participation.

Jumo Health and Areti Health share a focus on real execution outcomes. The partnership is designed to help sponsors improve advancement quality and participation durability without replacing sites, CROs, or existing clinical infrastructure. PRISM works across those systems, moving preventable education, expectation-setting, and friction detection upstream while giving study teams clearer readiness context.

AI should not make unreadiness move faster.

It should help the trial recognize and resolve it sooner.

About PRISM.

PRISM is Jumo Health's Patient Readiness and Intelligence System. It combines real-world data, social and behavioral determinants of health, behavioral science, health literacy, human-centered design, and AI-enabled execution to identify eligible patients, assess readiness, govern advancement, and protect participation through completion.

PRISM is designed to complement sponsor, CRO, site, and technology infrastructure. It converts readiness from an assumed patient characteristic into an operational signal that can shape recruitment, enrollment, retention, and completion decisions.

About Jumo Health.

Jumo Health is a Patient Experience Organization focused on whether patients are prepared to participate and remain engaged once the realities of a clinical trial begin. The company combines behavioral science, health literacy, human-centered design, real-world data, social determinants of health, and AI-enabled execution to make readiness measurable and actionable across the trial lifecycle.

About Areti Health.

Areti Health is an AI technology company developing conversational, generative, and agentic systems for clinical research. Its technology supports patient interaction, clinical-data workflows, pre-qualification, scheduling, follow-up, and coordination across research operations.

Media contact.

For additional information, email readiness@jumohealth.com.

Related announcement

Jumo Health Launches PRISM™, Defining a New Category of Readiness-Based Clinical Trial Execution →